173 related articles for article (PubMed ID: 31081680)
1. The Role of Polyethylene Glycol Size in Chemical Spectra, Cytotoxicity, and Release of PEGylated Nanoliposomal Cisplatin.
Shirzad M; Jamehbozorgi S; Akbarzadeh I; Aghabozorg HR; Amini A
Assay Drug Dev Technol; 2019 Jul; 17(5):231-239. PubMed ID: 31081680
[TBL] [Abstract][Full Text] [Related]
2. Supramolecular hydrogels from cisplatin-loaded block copolymer nanoparticles and α-cyclodextrins with a stepwise delivery property.
Zhu W; Li Y; Liu L; Chen Y; Wang C; Xi F
Biomacromolecules; 2010 Nov; 11(11):3086-92. PubMed ID: 20958000
[TBL] [Abstract][Full Text] [Related]
3. PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation.
Shaji J; Menon I
Pharm Nanotechnol; 2017; 5(2):119-137. PubMed ID: 28462699
[TBL] [Abstract][Full Text] [Related]
4. Enhanced Efficacy of PEGylated Liposomal Cisplatin: In Vitro and In Vivo Evaluation.
Ghaferi M; Asadollahzadeh MJ; Akbarzadeh A; Ebrahimi Shahmabadi H; Alavi SE
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31952316
[TBL] [Abstract][Full Text] [Related]
5. Length effect of methoxy poly(ethylene oxide)-b-[poly(ε-caprolactone)-g-poly(methacrylic acid)] copolymers on cisplatin delivery.
Chen HY; Lo YL; Wu PL; Lo PC; Wang LF
Colloids Surf B Biointerfaces; 2017 Aug; 156():243-253. PubMed ID: 28535473
[TBL] [Abstract][Full Text] [Related]
6. PEGylated liposomes of anastrozole for long-term treatment of breast cancer: in vitro and in vivo evaluation.
Shavi GV; Sreenivasa Reddy M; Raghavendra R; Nayak UY; Kumar AR; Deshpande PB; Udupa N; Behl G; Dave V; Kushwaha K
J Liposome Res; 2016; 26(1):28-46. PubMed ID: 25853340
[TBL] [Abstract][Full Text] [Related]
7. pH-Promoted Release of a Novel Anti-Tumour Peptide by "Stealth" Liposomes: Effect of Nanocarriers on the Drug Activity in Cis-Platinum Resistant Cancer Cells.
Sacchetti F; Marverti G; D'Arca D; Severi L; Maretti E; Iannuccelli V; Pacifico S; Ponterini G; Costi MP; Leo E
Pharm Res; 2018 Sep; 35(11):206. PubMed ID: 30209680
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin Loaded Poly(L-glutamic acid)-g-Methoxy Poly(ethylene glycol) Complex Nanoparticles for Potential Cancer Therapy: Preparation, In Vitro and In Vivo Evaluation.
Yu H; Tang Z; Li M; Song W; Zhang D; Zhang Y; Yang Y; Sun H; Deng M; Chen X
J Biomed Nanotechnol; 2016 Jan; 12(1):69-78. PubMed ID: 27301173
[TBL] [Abstract][Full Text] [Related]
9. Polymeric nanoparticles with encapsulated superparamagnetic iron oxide and conjugated cisplatin for potential bladder cancer therapy.
Huang C; Neoh KG; Xu L; Kang ET; Chiong E
Biomacromolecules; 2012 Aug; 13(8):2513-20. PubMed ID: 22793172
[TBL] [Abstract][Full Text] [Related]
10. Development of curcumin-loaded methoxy poly(ethylene glycol)-block- poly(caprolactone)-block-poly(1, 4, 8-Trioxa [4.6] spiro-9-undecanone) nanoparticles and studies on their in vitro anti-tumor activities.
Shi Y; Ma W; Gao M; Yang Y
Colloids Surf B Biointerfaces; 2019 Dec; 184():110525. PubMed ID: 31585307
[TBL] [Abstract][Full Text] [Related]
11. Development of a novel liposomal nanoparticle formulation of cisplatin to breast cancer therapy.
Ghafari M; Haghiralsadat F; Khanamani Falahati-Pour S; Zavar Reza J
J Cell Biochem; 2020 Jul; 121(7):3584-3592. PubMed ID: 31907989
[TBL] [Abstract][Full Text] [Related]
12. Designing and in-vitro characterization of micelle forming amphiphilic PEGylated rapamycin nanocarriers for the treatment of gastric cancer.
Kumar PV; Lokesh BV
Curr Drug Deliv; 2014; 11(5):613-20. PubMed ID: 25268676
[TBL] [Abstract][Full Text] [Related]
13. Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- caprolactone) bearing pendant hydroxyl groups as nanocarriers for doxorubicin delivery.
Chang L; Deng L; Wang W; Lv Z; Hu F; Dong A; Zhang J
Biomacromolecules; 2012 Oct; 13(10):3301-10. PubMed ID: 22931197
[TBL] [Abstract][Full Text] [Related]
14. Redox-sensitive micelles assembled from amphiphilic mPEG-PCL-SS-DTX conjugates for the delivery of docetaxel.
Zhang H; Wang K; Zhang P; He W; Song A; Luan Y
Colloids Surf B Biointerfaces; 2016 Jun; 142():89-97. PubMed ID: 26938324
[TBL] [Abstract][Full Text] [Related]
15. Incorporation of cisplatin into PEG-wrapped ultrapurified large-inner-diameter MWCNTs for enhanced loading efficiency and release profile.
Sui L; Yang T; Gao P; Meng A; Wang P; Wu Z; Wang J
Int J Pharm; 2014 Aug; 471(1-2):157-65. PubMed ID: 24853461
[TBL] [Abstract][Full Text] [Related]
16. Hepatoma-targeting and pH-sensitive nanocarriers based on a novel D-galactopyranose copolymer for efficient drug delivery.
Ding Y; Han J; Tian B; Han J; Zhang J; Zheng H; Han Y; Pei M
Int J Pharm; 2014 Dec; 477(1-2):187-96. PubMed ID: 25455771
[TBL] [Abstract][Full Text] [Related]
17. Comparison, synthesis and evaluation of anticancer drug-loaded polymeric nanoparticles on breast cancer cell lines.
Eatemadi A; Darabi M; Afraidooni L; Zarghami N; Daraee H; Eskandari L; Mellatyar H; Akbarzadeh A
Artif Cells Nanomed Biotechnol; 2016 May; 44(3):1008-17. PubMed ID: 25707442
[TBL] [Abstract][Full Text] [Related]
18. Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate.
Li X; Li R; Qian X; Ding Y; Tu Y; Guo R; Hu Y; Jiang X; Guo W; Liu B
Eur J Pharm Biopharm; 2008 Nov; 70(3):726-34. PubMed ID: 18634874
[TBL] [Abstract][Full Text] [Related]
19. Preparation, characterization, and cytotoxic effects of liposomal nanoparticles containing cisplatin: an in vitro study.
Poy D; Akbarzadeh A; Ebrahimi Shahmabadi H; Ebrahimifar M; Farhangi A; Farahnak Zarabi M; Akbari A; Saffari Z; Siami F
Chem Biol Drug Des; 2016 Oct; 88(4):568-73. PubMed ID: 27178305
[TBL] [Abstract][Full Text] [Related]
20. Low systemic toxicity nanocarriers fabricated from heparin-mPEG and PAMAM dendrimers for controlled drug release.
Thanh VM; Nguyen TH; Tran TV; Ngoc UP; Ho MN; Nguyen TT; Chau YNT; Le VT; Tran NQ; Nguyen CK; Nguyen DH
Mater Sci Eng C Mater Biol Appl; 2018 Jan; 82():291-298. PubMed ID: 29025661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
